Introduction
Liver cancer, also known as hepatic cancer, is a dangerous adversary that develops in liver cells. This subtle disease is a major global health hazard, and its prevalence has been continuously rising. Chemotherapy is an essential component of the entire arsenal of treatments for liver cancer, playing a critical role in the management and treatment of this disease.1
Importance of chemotherapy in liver cancer treatment
Chemotherapy is an important part of the overall care of liver cancer. Because of its systemic approach, it can target cancer cells throughout the body, making it especially useful in cases when tumours are difficult to find or have spread. Chemotherapy is important for shrinking tumours prior to surgery, lowering the chance of recurrence after surgery, and providing palliative care in advanced stages.
It supplements existing treatment options and acts as a bridge for individuals waiting for a liver transplant. Chemotherapy regimens are being refined as part of ongoing research, underscoring their importance in the developing landscape of liver cancer treatment.2
Understanding liver cancer
Types of liver cancer
Hepatocellular carcinoma (HCC)
HCC, the most common type of liver cancer, begins in hepatocytes, the primary cells of the liver. Understanding the unique features of HCC is critical for developing effective chemotherapeutic methods.
Cholangiocarcinoma
Cholangiocarcinoma is a less common but equally difficult type of liver cancer that originates in the bile ducts, demanding specialist techniques for treatment, including chemotherapy.
Causes and risk factors
Chronic Hepatitis B and C
Persistent infection with hepatitis B or C viruses increases the risk of developing liver cancer considerably. Chemotherapy is essential in the treatment of viral-induced liver tumours because it slows the course of the illness.
Cirrhosis
Chronic liver disorders, which frequently lead to cirrhosis, are major risk factors for liver cancer. Chemotherapy is useful in treating cancer in the context of cirrhotic liver disease.
Alcohol consumption
Alcohol abuse is a known risk factor for liver cancer. Chemotherapy interventions are designed to reduce the effects of alcohol-related liver impairment while also combating cancer cells.
Obesity
The global obesity epidemic has contributed to an increase in liver cancer cases. Chemotherapy is an important strategy in the fight against liver cancer in those who have obesity-related risk factors.
Role of chemotherapy in liver cancer treatment
Chemotherapy is a cornerstone in the complex tapestry of liver cancer treatment, providing a diverse approach to combating this powerful illness.
Basics of chemotherapy
Definition
Chemotherapy is a systemic treatment approach that uses powerful medications to prevent cancer cell development. Chemotherapy, unlike targeted treatments like surgery or radiation therapy, circulates throughout the body, making it particularly effective against cancer cells that have spread beyond the primary tumour.
How chemotherapy works
Chemotherapy interferes with cancer cells' rapid division and development. Chemotherapy medications try to slow disease progression by targeting cells at various cell cycle stages. This method is especially important in liver cancer, where tumours can be difficult to detect and may involve several places inside the liver.3
Goals of chemotherapy in liver cancer
Shrink tumours before surgery
Neoadjuvant chemotherapy is used to shrink tumours to make surgical intervention more possible and successful. This pre-surgical shrinkage increases the odds of a successful procedure and promotes better patient outcomes.
Destroy cancer cells
Adjuvant chemotherapy, administered after surgery, aims to eliminate any remaining cancer cells. This phase of chemotherapy tries to reduce the chance of cancer recurrence by targeting remaining malignant cells, promoting long-term remission.
Relieve symptoms and improve quality of life
Chemotherapy plays an important part in palliative care when a cure is not possible. Chemotherapy improves the overall quality of life for people with advanced liver cancer by reducing symptoms such as pain or discomfort and decreasing the course of the illness.
Chemotherapy drugs used for liver cancer
Sorafenib
This targeted therapy medication inhibits particular cancer cell proliferation and angiogenesis processes. Sorafenib is frequently administered for advanced hepatocellular carcinoma (HCC) and has been found to improve overall survival.
Lenvatinib
Lenvatinib, another targeted treatment, blocks numerous pathways in tumour proliferation. It is approved to treat unresectable HCC and has shown efficacy in both first- and second-line settings.
Doxorubicin
Doxorubicin is a chemotherapeutic medication in the anthracycline class. It inhibits DNA synthesis and is used to treat advanced liver cancer, frequently in conjunction with other drugs.
5-Fluorouracil
5-Fluorouracil, an antimetabolite medication, inhibits cancer cell development by interfering with DNA and RNA synthesis. It is used alone or in conjunction with other medications in various chemotherapy regimens for liver cancer.
Administration of chemotherapy
Methods of administration
Oral chemotherapy
Patients who embrace the ease of oral chemotherapy can take prescribed drugs in pill or liquid form, providing flexibility and autonomy in controlling their treatment. This approach is especially useful for long-term or maintenance treatments.
Intravenous (IV) chemotherapy
IV administration, a cornerstone of many chemotherapy regimens, includes the direct infusion of medicines into the circulation. This approach enables quick dispersion throughout the body, effectively targeting cancer cells.
Transarterial chemoembolization (TACE)
TACE delivers chemotherapy directly to the tumour location in a localised method. This method combines chemotherapy drug infusion with the temporary closure of blood arteries supplying the tumour, increasing drug concentration at the cancer site while limiting systemic exposure.4
Treatment schedule and cycles
Chemotherapy is often administered in cycles, comprising treatment and recovery periods. The frequency and duration of these cycles are adjusted to the patient's tumour, response to treatment, and overall health. The treatment program is meticulously planned to maximise therapeutic advantages while allowing the body to recover between sessions.
Side effects of chemotherapy
Common side effects
- Nausea and vomiting: Nausea and vomiting are common adverse effects that can be treated with antiemetic medicines. These medications help to relieve the uncomfortable symptoms, making chemotherapy more bearable for patients
- Fatigue: Fatigue is a common side effect of chemotherapy that often interferes with daily tasks. Adequate rest, balanced eating, and modest exercise can all help to reduce fatigue and improve the patient's general well-being
- Hair loss: Chemotherapy-induced hair loss is a well-known side effect that affects patients' physical appearance and emotional well-being. While not all chemotherapy medications cause hair loss, patients should consider supportive measures such as wigs, scarves, or counselling to help them cope with these changes5
Management of side effects
Supportive medications
Anti-nausea medications, pain painkillers, and blood cell boosters are among the supporting treatments available. These are used in conjunction with chemotherapy to manage side effects and improve the patient's comfort.
Lifestyle adjustments
Patients undergoing chemotherapy can benefit from lifestyle changes to reduce adverse effects. Maintaining a well-balanced diet, staying hydrated, and incorporating mild exercise into daily routines all help to overall physical and mental resilience.
Considerations and precautions
Patient eligibility for chemotherapy
A detailed review of a patient's overall health, current medical conditions, and the specific characteristics of the liver cancer is required to determine their appropriateness for chemotherapy. Age, overall fitness, and the presence of other health concerns all influence the choice to start chemotherapy. Open communication between patients and healthcare providers is critical in assessing the potential advantages against the dangers and ensuring that the selected treatment matches the individual's well-being.
Assessing liver function before treatment
Given the liver's essential role in drug processing, evaluating its function prior to starting chemotherapy is critical. Liver function tests, which include measurements of enzyme levels and bilirubin, provide information about the organ's health. This evaluation assists healthcare practitioners in establishing the proper dosage and medicines, reducing the risk of toxicity and improving the overall safety of the chemotherapy regimen.
Potential interactions with other medications
The complicated interplay between chemotherapeutic treatments and other medications requires careful study of potential interactions. Certain medicines, including over-the-counter vitamins, can reduce the effectiveness or safety of chemotherapy. Healthcare providers carefully analyse a patient's whole drug list, altering prescriptions as needed to minimise adverse interactions and achieve the best therapeutic outcome.
Response assessment
Monitoring tumour response
Imaging studies (CT Scans, MRI)
Regular imaging studies are crucial in tracking the tumour's response to chemotherapy. CT scans and magnetic resonance imaging (MRI) give detailed visualisations, allowing healthcare providers to assess tumour size, shape, and density changes.
Tumor markers
Blood tests that measure specific tumour markers provide additional insight into the response to chemotherapy. Elevated or decreased levels of these markers indicate therapy success, guiding therapeutic modifications.6
Adjusting chemotherapy based on response
The dynamic nature of cancer necessitates a flexible approach to treatment. Healthcare practitioners may change the chemotherapy treatment based on the evaluation of the response. To maximize the treatment's impact on the cancer, this adjustment could include changing drug dosages, switching to new drugs, or researching complementary therapies.
Summary
Considerations and precautions are the core of tailored care in the complex environment of liver cancer treatment. Patient eligibility, liver function testing, and awareness of potential pharmaceutical interactions all contribute to a treatment plan that is effective and tailored to each individual's specific needs.
As we navigate the present, the future of liver cancer treatment contains promise and opportunity. Ongoing research focuses on improving existing medicines and discovering novel techniques to improve treatment outcomes. Advances in targeted medicines, immunotherapies, and precision medicine are expected to change the landscape, providing patients with more effective and less invasive treatment options.7
In concluding this examination of chemotherapeutic concerns, response assessments, and future advances, the collaborative efforts of healthcare providers and researchers illuminate a road forward. By consistently improving our understanding of liver cancer and the complexities of chemotherapy, we can chart a course toward better outcomes, higher quality of life, and, ultimately, a brighter future for individuals affected by this difficult disease.
References
- Rossetto A, De Re V, Steffan A, Ravaioli M, Miolo G, Leone P, et al. Carcinogenesis and metastasis in liver: cell physiological basis. Cancers [Internet]. 2019 Nov [cited 2023 Dec 13];11(11):1731. Available from: https://www.mdpi.com/2072-6694/11/11/1731.
- Liu CY, Chen KF, Chen PJ. Treatment of liver cancer. Cold Spring Harb Perspect Med [Internet]. 2015 Sep [cited 2023 Dec 13];5(9):a021535. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561392/.
- Schirrmacher V. From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review). International Journal of Oncology [Internet]. 2019 Feb 1 [cited 2023 Dec 13];54(2):407–19. Available from: https://www.spandidos-publications.com/10.3892/ijo.2018.4661.
- Raoul JL, Forner A, Bolondi L, Cheung TT, Kloeckner R, de Baere T. Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence. Cancer Treatment Reviews [Internet]. 2019 Jan 1 [cited 2023 Dec 13];72:28–36. Available from: https://www.sciencedirect.com/science/article/pii/S0305737218301944.
- Aslam MS, Naveed S, Ahmed A, Abbas Z, Gull I, Athar MA. Side effects of chemotherapy in cancer patients and evaluation of patients opinion about starvation based differential chemotherapy. Journal of Cancer Therapy [Internet]. 2014 Jul 7 [cited 2023 Dec 13];2014. Available from: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=48061.
- Minami Y, Kudo M. Imaging modalities for assessment of treatment response to nonsurgical hepatocellular carcinoma therapy: contrast-enhanced us, ct, and mri. Liver Cancer [Internet]. 2015 Apr 8 [cited 2023 Dec 13];4(2):106–14. Available from: https://doi.org/10.1159/000367733.
- Deng GL, Zeng S, Shen H. Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges. World J Hepatol [Internet]. 2015 Apr 18 [cited 2023 Dec 13];7(5):787–98. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404384/.
